{"id":"NCT03301051","sponsor":"Medicago","briefTitle":"Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults","officialTitle":"A Randomized, Observer-blind, Placebo-controlled, Multicenter, Phase 3 Study to Assess the Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Adults 18-64 Years of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-08-31","primaryCompletion":"2018-05-02","completion":"2018-05-09","firstPosted":"2017-10-04","resultsPosted":"2023-08-14","lastUpdate":"2023-08-14"},"enrollment":10160,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Virus Diseases","RNA Virus Infections","Respiratory Tract Diseases","Respiratory Tract Infections","Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Quadrivalent VLP Vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"Quadrivalent VLP Vaccine","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This Phase 3 study is intended to assess the efficacy of the Quadrivalent VLP Influenza Vaccine during the 2017-2018 influenza season in healthy adults 18 to 64 years of age. One dose of Quadrivalent VLP Influenza Vaccine (30 Î¼g/strain) or of placebo will be administered to approximately 10,000 participants","primaryOutcome":{"measure":"Number of Occurrences of Protocol-Defined Respiratory Illness Caused by Vaccine-Matched Influenza Strains","timeFrame":"Day 14 (post-vaccination) up to ~8 months","effectByArm":[{"arm":"Quadrivalent VLP Vaccine","deltaMin":110,"sd":null},{"arm":"Placebo","deltaMin":169,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":73,"countries":["United States","Canada","Finland","Germany","Philippines","Thailand","United Kingdom"]},"refs":{"pmids":["33065035"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":55,"n":5064},"commonTop":["Upper respiratory tract infection","Headache","Influenza like illness","Nasopharyngitis","Oropharyngeal pain"]}}